Cipla Ltd.
BSE: 500087 | Sector: Health care |
NSE: CIPLA | ISIN Code: INE059A01026 |
BSE 00:00 | 18 Aug | 1032.10 |
6.60 (0.64%) |
OPEN
1026.25 |
HIGH
1033.55 |
LOW
1007.00 |
NSE 00:00 | 18 Aug | 1032.20 |
6.45 (0.63%) |
OPEN
1028.50 |
HIGH
1034.05 |
LOW
1007.35 |
OPEN | 1026.25 |
PREVIOUS CLOSE | 1025.50 |
VOLUME | 29688 |
52-Week high | 1083.15 |
52-Week low | 850.00 |
P/E | 28.47 |
Mkt Cap.(Rs cr) | 83,290 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 915.75 | -4.70 | -0.51 | 15585.98 |
Dr Reddy's Labs | 4225.55 | -94.05 | -2.18 | 14405.20 |
Cipla | 1032.10 | 6.60 | 0.64 | 13091.79 |
Lupin | 688.50 | 0.95 | 0.14 | 11771.67 |
Aurobindo Pharma | 582.95 | 2.55 | 0.44 | 11287.14 |
Divi's Lab. | 3744.40 | -5.05 | -0.13 | 8879.82 |
Alkem Lab | 2927.55 | -12.40 | -0.42 | 8829.81 |
Zydus Lifesci. | 394.10 | -5.65 | -1.41 | 7981.90 |
Glenmark Pharma. | 399.60 | -3.75 | -0.93 | 7567.93 |
Torrent Pharma. | 1560.25 | 3.05 | 0.20 | 6742.32 |
Apollo Hospitals | 4270.55 | -30.30 | -0.70 | 6098.30 |
Ipca Labs. | 925.00 | 4.65 | 0.51 | 5399.36 |
Alembic Pharma | 654.70 | -1.95 | -0.30 | 5051.44 |
Abbott India | 19012.00 | -188.15 | -0.98 | 4919.27 |
Laurus Labs | 590.25 | -1.20 | -0.20 | 4707.04 |
Gland Pharma | 2399.10 | 29.35 | 1.24 | 4400.71 |
Granules India | 325.25 | -1.70 | -0.52 | 3238.44 |
Glaxosmi. Pharma | 1478.60 | 16.35 | 1.12 | 3217.51 |
Ajanta Pharma | 1258.65 | -15.30 | -1.20 | 3140.64 |
Sanofi India | 6375.00 | -33.40 | -0.52 | 2956.60 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices